Revolutionizing the Management of Multiple Sclerosis in Older Adults
Experts call for a major overhaul in managing multiple sclerosis in adults over 50, emphasizing personalized care, improved diagnostics, and inclusive research to adapt to demographic shifts.
Global experts, including leading researchers from Monash University, have collaboratively developed new guidelines aimed at improving the care of individuals over 50 living with multiple sclerosis (MS). As advancements in medical treatments increase the lifespan of MS patients, a significant demographic shift has occurred, with more than half of the global MS population now aged 50 and above. Despite this, current clinical trials, diagnostic tools, and treatment guidelines have not adapted to this aging population, often leading to challenges in accurate diagnosis, effective treatment, and quality of life improvements.
The consensus statement, published in Nature Reviews Neurology, emphasizes the urgent need for a paradigm shift in MS management for older adults. First author Associate Professor Anneke van der Walt from Monash University highlights that traditional approaches, designed for younger patients, overlook age-related changes and comorbidities, creating blind spots in care. The statement advocates for better diagnostic frameworks to distinguish MS from common age-related conditions, innovative tools to monitor disease progression considering biological aging, and tailored treatment strategies that include safe de-escalation or discontinuation of therapy when appropriate.
Additionally, the guidelines call for greater inclusion of older adults in clinical research to build evidence-based practices suited for this group. They also promote holistic, multidisciplinary care models incorporating physical activity, mental health support, and cardiovascular risk management.
Co-author Professor Helmut Butzkueven emphasizes that aging fundamentally alters MS pathology, necessitating updated science and care models that reflect this reality. The guideline sets out a roadmap to address critical gaps and urges funding agencies and policymakers to prioritize research involving older MS patients, especially those with comorbidities often excluded from trials.
Importantly, the statement underscores the importance of empowering people living with MS through enhanced access to information, personalized education, and active participation in their care decisions, ensuring that treatment evolves alongside demographic changes. This comprehensive approach aims to improve health outcomes and quality of life for the aging MS population.
Source: https://medicalxpress.com/news/2025-07-global-experts-multiple-sclerosis-older.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Difficulty Lifting 5 kg as a Key Indicator of Future Health Risks in Older Adults
A simple 5 kg lifting test can reveal early signs of chronic diseases and decreased quality of life in older adults, according to recent research. This accessible method offers an easy way for early health screening and preventative care.
Innovative Cyclic Disulfide Lipids Show Promise in Halting Cancer Growth in Mice
Nagoya University researchers have created cyclic disulfide lipids that dramatically enhance mRNA delivery, showing promise in stopping tumor growth in mice and advancing cancer vaccine development.
Emerging Approaches: Targeting the Brain for New Type 1 Diabetes Treatments
New research highlights the potential of targeting the brain, particularly the hormone leptin, to develop innovative treatments for type 1 diabetes and its dangerous complication, diabetic ketoacidosis.
Hospital Maintains Life Support for Brain-Dead Woman in Georgia to Allow Fetus to Develop Amid Strict Abortion Laws
In Georgia, a brain-dead woman has remained on life support for over three months to allow her fetus to develop, highlighting legal and ethical challenges posed by strict abortion laws in complex cases. Learn more about this unprecedented situation.